摘要 |
Disclosed are immunogenic compositions, and methods for their use in the formulation and administration of therapeutic and prophylactic pharmaceutical agents. In particular, the invention provides immunogenic compositions and methods for preventing, treating, and/or ameliorating microbial infection, including, for example, influenza, or one or more symptoms thereof. The immunogenic peptides derive from influenza A, combining NA (neuraminidase), HA (hemagglutinin) and/or M2e (matrix protein 2) epitopes, optionally for use in combination with TT P2 helper peptide (from tetanus toxin). |